Primary Care

Myeloproliferative Neoplasms

Questions discussed in this category

For patients with essential thrombocythemia already on prophylactic dose DOACs, do you defer starting aspirin?

2 Answers available

Is there a role to continue aspirin in patients with myeloproliferative disorders who have never had a thrombotic event that are starting DOAC for stroke prophylaxis with newly diagnosed atrial fibrillation?

2 Answers available

How would you manage a patient with erythrocytosis of unknown cause in pregnancy?

MPN work-up negative

1 Answer available

What are your recommendations for management of patients with familial polycythemia due to EPOR mutation during pregnancy?

1 Answer available

In patients with thrombocytosis with negative MPN workup from peripheral blood and bone marrow, is there a role for daily 81mg aspirin or other treatment?

2 Answers available

How do you manage testosterone replacement therapy-induced erythrocytosis?

Do you recommend therapeutic phlebotomy to a certain Hct goal? Any strong evidence for thromboembolic risk related to erythrocytosis or if this is mit...

3 Answers available

Papers discussed in this category

Haematologica, 2022 May 01

Hemorrhage in patients with polycythemia vera receiving aspirin with an anticoagulant: a prospective, observational study.

Related Topics in Primary Care